-
Stay Connected:
Sign up for the Florida Law Review Mailing List
eReader Ready:
Current Issue
Jan. 2013, Vol. 65, No. 1
Articles
David Haddock, Tonja Jacobi, & Matthew Sag, League Structure &Stadium Rent Seeking— the Role of Antitrust Revisited
Steven J. Cleveland, Resurrecting Deference to the Securities and Exchange Commission: Mark Cuban Trading on Inside information
Janai S. Nelson, The First Amendment, Equal Protection and Felon Disenfranchisement: A New Viewpoint
Sergio J. Campos, Erie as a Choice of Enforcement Defaults
Hanah Metchis Volokh, Constitutional Authority Statements in Congress
Sapna Kumar, The Accidental Agency?
Christian Turner, State Action Problems
Tag Archives: generic companies
Michael A. Carrier, A Real-World Analysis of Pharmaceutical Settlements: The Missing Dimension of Product Hopping
62 Fla. L. Rev. 1009 (2010) | | | | ABSTRACT :: The pharmaceutical industry plays an important role in improving human health. But it also provides the setting for some of the most concerning issues in the patent-antitrust intersection … Continue reading
Posted in Antitrust & Trade Law, Patent Law, Uncategorized
Tagged anticompetitive effects, brand-name, Carrier, generic companies, human health, lethal combination, Missing Dimension, patent challenge, pharmaceutical competition, pharmaceutical firms, Pharmaceutical Settlements, product hopping, Real-World Analysis, settlements, significant roadblock
Comments Off